SCHEMBL8901763

SCHEMBL8901763

COc1ccc(OC)c2c1CC(C(=O)OCc1ccc([N+](=O)[O-])cc1)OC2C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.46
MAPT P10636 4/20 0.44
ALDH1A1 P00352 2/20 0.44
HPGD P15428 1/20 0.44
PDE7A Q13946 1/20 0.41
PDE3A Q14432 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
RAB9A P51151 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
NPC1 O15118 1/20 0.41
NFKB1 P19838 1/20 0.41
NFKB2 Q00653 1/20 0.41
RELA Q04206 1/20 0.41
ATM Q13315 1/20 0.40
MITF O75030 1/20 0.40
LMNA P02545 1/20 0.39
NTSR1 P30989 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
GAA P10253 1/20 0.39
MAPK1 P28482 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8901817 0.82 HTT (0.48) HTTMAPTALDH1A1HPGDPDE7A
SCHEMBL8902384 0.77 HTT (0.42) HTTMAPTALDH1A1HPGDPDE7A
SCHEMBL8902582 0.77 HTT (0.42) HTTMAPTALDH1A1HPGDPDE7A
SCHEMBL8901821 0.76 L3MBTL1 (0.39) HTTMAPTALDH1A1RAB9ASMN1; SMN2
SCHEMBL8901723 0.75 ALDH1A1 (0.45) HTTMAPTALDH1A1HPGDTDP1
SCHEMBL27461289 0.70 KDM4E (0.51) HTTMAPTALDH1A1HPGDTDP1
SCHEMBL8902192 0.70 TDP1 (0.44) MAPTALDH1A1HPGDTDP1RAB9A
SCHEMBL8901768 0.70 TDP1 (0.44) MAPTALDH1A1HPGDTDP1RAB9A
SCHEMBL18318470 0.69 TDP1 (0.51) MAPTALDH1A1HPGDTDP1RAB9A
SCHEMBL11618583 0.69 ALDH1A1 (0.46) HTTMAPTALDH1A1HPGDTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5593970-A ANTITUMOR AND ANTCARCINOGENIC AGENTS; TRETMENT OF CANCEROUS BONE MARROW BEFORE REGRAFTING BIOCHEM PHARMA INC. (CA) 1997-01-14 US disclosed